Medisafe
PrivateLast Round
Series C
Feb 25, 2021
Total Funding Raised
$51.5M
Company Overview
Medisafe operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series C round in February 2021.
Medisafe is a digital health company that provides a cloud-based medication management platform to improve patient adherence through personalized engagement and real-time intelligence for pharmaceutical partners.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Medical Devices, Healthcare Analytics, NLP & Conversational AI, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Data as a Service, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medisafe Comparables
Compare Medisafe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealthPrize Technologies | 83% | |
| Redi.Health | 83% | |
| Redcare Pharmacy | 80% |
For institutional investors. Book with your work email.
Medisafe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 25, 2021 | ||||
| Series B | Mar 1, 2017 | ||||
| Series A | Jan 13, 2015 | ||||
| Seed | Sep 23, 2013 | ||||
| Accelerator | Sep 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medisafe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Menora Mivtachim Group | Series C |
| Lool Ventures | Series A, Series B, Series C, Seed |
| 7wire Ventures | Series A, Series B, Series C |
| M Ventures | Series B, Series C |
| Qualcomm Ventures | Series A, Series B, Series C |
| Leumi Partners | Series C |
| Consensus Business Group | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Mandatory premium subscription for core features launched January 1, 2026.
- Oct 1, 2025
Reached over 14 million registered patients globally.
For institutional investors. Book with your work email.
Medisafe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medisafe's valuation, stock price, and market status.
Is Medisafe a public or private company?
Medisafe is a private company.
What is the current stock price of Medisafe?
Medisafe is a private company, so its shares have no public market price. Caplight tracks Medisafe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medisafe worth (valuation)?
Valuation information for Medisafe is not publicly available.
Can I buy Medisafe stock?
Medisafe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medisafe's last funding round?
Medisafe's most recent funding round was Series C on February 25, 2021.
Who are the main investors in Medisafe?
Key investors in Medisafe include Lool Ventures, Sanofi Ventures, Triventures, Pitango Venture Capital, Octopus Ventures.
Will Medisafe IPO soon?
No public IPO plans have been announced for Medisafe.
How can I track Medisafe secondary market activity?
Caplight tracks bids, offers, and trades in Medisafe's shares on secondary markets.